Conclave Pharma Private Limited

Conclave Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24232DL2005PTC133410 Incorporated 25 February 2005 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹1.58 Lakh
▲ 18% YoY
Net loss · FY 2025
₹39,452
Net margin -24.9%
EBITDA · FY 2025
-₹34,636
EBITDA margin -21.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
21 yrs
Est. 2005
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Conclave Pharma Private Limited

Data last updated:

Conclave Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 February 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC133410. Its GSTIN is 07AACCC7925R1Z1 (Delhi).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sameer Sud and Nishant Choudhary.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No.19 New Market Ramesh Nagar, New Delhi, Delhi, India – 110015.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.58 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹39,452 (net margin -24.9%) and EBITDA of -₹34,636 (EBITDA margin -21.9%). Revenue has declined at a compounded annual rate (CAGR) of 72% over three years and 74% over five years.

Court records list 3 cases involving the company, including 3 filed by the company.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232DL2005PTC133410
Registration Number 133410
Incorporation Date 25 February 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Conclave Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Shop No.19 New Market Ramesh Nagar, New Delhi, Delhi, India – 110015
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Conclave Pharma Private Limited, buy the company report.

Comprehensive company report
Conclave Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Conclave Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Conclave Pharma Private Limited, buy the company report.

Financials of Conclave Pharma Private Limited

FY 2025 filings available

Conclave Pharma Private Limited reported revenue of ₹1.58 Lakh (up 18% YoY) for FY 2025.

Revenue · FY 2025
₹1.58 Lakh ▲ 18%
Net loss · FY 2025
₹39,452 margin -24.9%
EBITDA · FY 2025
-₹34,636 margin -21.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 18%
3 years · compounded
▼ 72%
5 years · compounded
▼ 74%
EBITDA CAGR growth
1 year
▼ 132%
3 years · compounded
▼ 28%
5 years · compounded
▼ 15%

Revenue rose 18% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 74%. EBITDA fell 132% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹34,636
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹39,452
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-21.9%
Net Profit Margin-24.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Conclave Pharma Private Limited, buy the company report.

Board of directors of Conclave Pharma Private Limited

Conclave Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arun AroraAdditional Director06 Jun 20206 Years 4 MonthsCurrent
Sameer SudDirector15 Sep 200818 Years 1 MonthsCurrent
Nishant ChoudharyDirector15 Sep 200818 Years 1 MonthsCurrent

Peer comparison

Conclave Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Absolute Biotech Private Limited₹1.61 Lakh (FY 2018)Mandsaur, Madhya Pradesh, India
Medleods Pharmaceuticals Private Limited₹1.6 Lakh (FY 2024)-4.0%Maharashtra, India
Conclave Pharma Private Limitedthis company₹1.58 Lakh (FY 2025)-₹39,452-24.9%18.0%New Delhi, Delhi, India
Elbrus Remedies and Formulations Private Limited₹1.57 Lakh (FY 2022)Jalalabad, Uttar Pradesh, India

To see the full peer comparison of Conclave Pharma Private Limited, buy the company report.

Auditor

Conclave Pharma Private Limited is audited by J D A & COMPANY for the financial year 2020.

Auditor firmFinancial yearFirm registration number
J D A & COMPANYFY 2020015377N

Shareholding

The shareholding of Conclave Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Conclave Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Conclave Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Conclave Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AACCC7925R1Z1DelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Conclave Pharma Private Limited, buy the company report.

Recent activity

Conclave Pharma Private Limited has 8 board changes on record since 2008: 3 appointments and 5 cessations. The latest: Mani Arora ceased to be Director on 23 Jul 2020.

AGM
Conclave Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Conclave Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Mani Arora ceased to be Director.
Appointed
Arun Arora was appointed as Additional Director.
Ceased
Kuldeep Kumar Gupta ceased to be Director.
Ceased
Sneh Gupta ceased to be Director.
Ceased
Anil Chaudhary ceased to be Director.
Ceased
Jaspal Singh ceased to be Director.
Appointed
Nishant Choudhary was appointed as Director.
Appointed
Sameer Sud was appointed as Director.
Incorporation
25 Feb 2005
Conclave Pharma Private Limited was registered on 25 Feb 2005 with Roc Delhi Ii & aged 21 years 8 months as per MCA records.

Frequently asked questions

Conclave Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 February 2005 (21+ years old) and is registered under CIN U24232DL2005PTC133410.

Conclave Pharma has 3 current directors:

The latest financial statements of Conclave Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Conclave Pharma is 07AACCC7925R1Z1, registered in Delhi.

The CIN (Corporate Identification Number) of Conclave Pharma is U24232DL2005PTC133410. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Conclave Pharma has 3 court cases on record: 3 filed by the company. Most are in the high courts.

Conclave Pharma was incorporated on 25 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Conclave Pharma by revenue are Absolute Biotech Private Limited, Medleods Pharmaceuticals Private Limited, Elbrus Remedies and Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Mani Arora ceased to be Director on 23 Jul 2020. Arun Arora was appointed as Additional Director on 06 Jun 2020. Kuldeep Kumar Gupta ceased to be Director on 18 Jun 2014. Conclave Pharma has 8 board changes on record in total.

The registered office of Conclave Pharma is at Shop No.19 New Market Ramesh Nagar, New Delhi, Delhi, India – 110015.

Conclave Pharma operates in the pharma industry, in the drug formulation and development segment.